| Literature DB >> 33646835 |
Abstract
SOURCE CITATION: Voysey M, Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99-111. 33306989.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33646835 DOI: 10.7326/ACPJ202103160-029
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391